Sun-Ranbaxy deal: CCI public scrutiny deadline ends today
The USD 4-billion deal would create the fifth largest specialty generics company in the world and the largest pharmaceutical company in India.
Sep 24, 2014, 17:10 PM IST
The USD 4-billion deal would create the fifth largest specialty generics company in the world and the largest pharmaceutical company in India.
Sep 24, 2014, 17:10 PM IST